BridgeBio Pharma BBIO Net product revenue — Cost of Revenue

Other product segments

Similar metrics at other companies

BIIBProduct revenue, net — Cost of sales, excluding amortization and impairment of acquired intangible assets

$478.7M+3.6%

BIIBProduct revenue, net — Total Revenue

$1.75B+1.5%

ILMNProduct revenue — Cost of revenue

$197M-1.7%

BMRNNet product revenues — Total revenues

$760.08M+3.5%

ROIVProduct revenue, net — Revenue, net

$0-100%

NBIXNet product sales — Total revenues

$811M+43.9%

Questions, answered.

What is BridgeBio Pharma's net product revenue — cost of revenue?

BridgeBio Pharma (BBIO) reported net product revenue — cost of revenue of $7.73M in Q1 2026.

How has BridgeBio Pharma's net product revenue — cost of revenue changed year-over-year?

BridgeBio Pharma's net product revenue — cost of revenue increased by 280.1% year-over-year, from $2.03M to $7.73M.

What does net product revenue — cost of revenue mean?

The direct costs incurred to manufacture and supply the pharmaceutical products sold by the company.

How do you interpret net product revenue — cost of revenue?

A decrease relative to revenue suggests improved manufacturing efficiency or economies of scale, whereas an increase may indicate rising production costs or supply chain inefficiencies.

How does net product revenue — cost of revenue compare across companies?

Comparable to cost of goods sold (COGS) reported by other pharmaceutical companies, typically benchmarked against gross margin percentages.